Abstract:Dominant cell type of neointima exhibited myofibroblast features and arose primarily from tissue external to the vein. Among differentially expressed genes identified by spatial transcriptomics, Fhl1 was strongly expressed in neointima. Fhl1 prevented NIH in vivo and cultured human veins through its anti‐inflammation and anti‐proliferation properties. Background Vein grafts are commonly employed in revascularisation surgery for multivessel coronary artery disease, yet neointimal hyperplasia (NIH) remains a critical impediment to the long‐term patency of these grafts. Despite this, effective methods to precisely identify and target interventions for the neointima are still inadequate. Methods In this study, Sprague–Dawley (SD) rats were used to establish an external jugular vein transplantation model, and the NIH pathophysiological process was tracked across 11 time points (0–35 days) using various histological stains. Spatial transcriptomics was performed on normal veins and 19‐day grafts to explore gene expression in neointimal regions. Immunohistochemical analysis identified neointima‐specific markers, while NIH progression was assessed in SD rats with four and a half LIM domains protein 1 (Fhl1) knockout and in human saphenous veins (HSV) with adenovirus‐mediated Fhl1 overexpression. Results Typical neointimal formation commenced by day 11 postgrafting and peaked at day 19. Neointimal cells originated from newly generated α‐SMA(+) repair cells located outside the grafted vein, displaying a hybrid fibroblast‐smooth muscle cell phenotype. Spatial transcriptomics identified stable and sustained Fhl1 expression within the neointima throughout the entire NIH phase. Systemic knockout of Fhl1 in SD rats via the phosphoinositide 3‐kinase pathway exacerbated graft inflammation, heightened cell proliferation, and accelerated NIH. Conversely, FHL1 overexpression in cultured HSV suppressed NIH. Conclusion These findings indicate that, following grafting into the arterial system, the newly formed repair cells external to the grafted vein play a pivotal role in NIH, with neointimal cells exhibiting stable and continuous Fhl1 expression. Fhl1 serves as a protective factor against NIH both in vivo and in HSV, likely due to its anti‐inflammatory and anti‐proliferative effects. Key points This study firstly used spatial transcriptomics technique to analyse the neointima and generated a specific neointimal transcriptomic atlas. Fhl1 exhibits specific and stable expression in the spatial region of the neointima. It has thus far the highest enrichment of expression in the neointima in NIH phases, suggesting that it is a prominent molecular biomarker of neointima. We generated rats with a Fhl1 deletion and found that insufficient Fhl1 expression caused an increase in the severity of vascular inflammation and proliferation during neointimal hyperplasia. Adenovirus‐mediated FHL1 overexpression in human saphenous vein have beneficial effects in preventing neointimal hyperplasia. These highlight its potential as a therapeutic target for mitigating vein graft failure associated with cardiovascular procedures. Spatial transcriptomics profiles and morphological observations demonstrated that a newly generated cell population outside the grafted vein with hybrid phenotype between SMCs and fibroblasts contributes to neointimal formation.

Early thrombus formation is required of eccentric and heterogenous neointimal hyperplasia under disturbed flow

Local Hemodynamic Disturbance Accelerates Early Thrombosis Of Small-Caliber Expanded Polytetrafluoroethylene Grafts

Experimental Study on Anastomotic Hemodynamics Using Tomographic Particle Image Velocimetry

Characterization of Neointima Lesions Associated with Arteriovenous Fistulas in a Mouse Model.

Improving the hemocompatibility of a porohyperelastic layered vascular graft using luminal reversal microflows

Experimental Study on Hemodynamics of an End-to-side Anastomosis

Single-Cell Transcriptome Analysis Reveals Dynamic Populations of Vascular Cells in Neointimal Hyperplasia

Fhl1, a new spatially specific protein, regulates vein graft neointimal hyperplasia

Transitional Flow in the Venous Side of Patient-Specific Arteriovenous Fistulae for Hemodialysis

Patient-specific hemodynamic markers co-localise with regions of neointimal hyperplasia in an arteriovenous graft

Abstract 313: TGF-beta Signaling Mediates Endothelial-to-mesenchymal Transition During Arteriovenous Fistula Remodeling in the Chronic Kidney Disease Environment

Early Adventitial Activation and Proliferation in a Mouse Model of Arteriovenous Stenosis: Opportunities for Intervention

Notch signaling in bone marrow-derived FSP-1 cells initiates neointima formation in arteriovenous fistulas

Abstract 3092: Smooth Muscle Cell Tgf-β Receptor Knockout Improves Arteriovenous Fistula Maturation Via Attenuation of Autophagy

Neointimal Hyperplasia after Endoluminal Injury in Mice is Dependent on Tissue Factor- and Angiopoietin-2 Dependent Interferon Gamma Production by Fibrocytes and Macrophages

Morphological Lesion Types Are Associated with Primary and Secondary Patency Rates after High-Pressure Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas

Rapid Development of Vein Graft Atheroma in ApoE-deficient Mice

Heterogeneous gene expression during early arteriovenous fistula remodeling suggests that downregulation of metabolism predicts adaptive venous remodeling

Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?

Inhibition of mitochondrial fission alters neo-intimal hyperplasia via PI3K/Akt signaling in arteriovenous fistulas

Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development